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Purpose: 17 β-estradiol (17β-E2) protects human lens epithelial cells against oxidative stress by preserving mitochondrial
function in part via the non-genomic rapid activation of prosurvival signal transduction pathways. The study described
herein  examined  whether  17β-E2  also  elicits  genomic  protection  by  influencing  the  expression  (and  activity)  of
mitochondrial-associated manganese superoxide dismutase (MnSOD) as a possible parallel mechanism by which 17β-E2
protects against oxidative stress.
Methods: Virally-transformed human lens epithelial cells (HLE-B3) were pre-incubated with 17β-E2, and mRNA or
protein lysates were collected over a time course ranging from 90 min to 24 h. Positive expression of lens epithelial cell
MnSOD mRNA was determined by semi-quantitative reverse transcriptase polymerase chain reaction (RT–PCR), and its
levels were monitored by real-time PCR up to 24 h after 17β-E2 administration. Western blot analysis was used to examine
the pattern of protein expression as influenced by 17β-E2 treatment. MnSOD activity as influenced by 17β-E2 was
determined by measuring enzymatic activity.
Results: A significant rapid increase in the activity of MnSOD was observed with HLE-B3 cells by 90 min post-bolus
addition of 17β-E2, which returned to control level by 240 min. Neither an increase in MnSOD mRNA nor in protein
expression was detected up through 24 h.
Conclusions: These data demonstrate that 17β-E2 rapidly and transiently increases the activity of MnSOD but influences
neither its mRNA expression nor its protein expression. The results suggest that (estrogen-activated) MnSOD plays an
important role against mitochondrial oxidative stress by diminishing reactive oxygen species, thus promoting cell survival.
Epidemiological  studies  have  indicated  a  higher
incidence of cataract formation in postmenopausal women as
compared to men of the same age, suggesting that the absence
of estrogens may contribute to their increased risk [1]. The
Beaver Dam Eye Study [2] and the Salisbury Eye Study [3]
both  found  a  protective  association  between  the  use  of
estrogen and the risk of cataract development. These findings
have been further substantiated in studies using rodent models
and cell cultures. Using a transgenic mouse model expressing
a  dominant-negative  form  of  estrogen  receptor  α,  which
inhibits estrogen receptor α function, it was demonstrated that
female  mice  spontaneously  formed  cortical  cataracts  after
puberty,  and  the  disease  progressed  with  age,  thereby
suggesting that the repression of (nuclear) estrogen action
induces cortical cataract [4]. Estrogen treatment diminished
the  incidence  of  cortical  cataracts  in  ovariectomized  rats
treated with methylnitrosourea (MNU) [5]. It has also been
reported  that  estrogen  protected  lenses  against  cataracts
induced by transforming growth factor-β (TGFβ) in cultured
rat lenses [6]. Numerous studies have established that the
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cytoprotective benefits of estrogen are achieved by its ability
to act via both genomic and non-genomic pathways [7].
Cataract is a worldwide leading cause of blindness and is
a multifactorial eye disease. While surgical procedures can
correct vision loss, this presents a large financial burden on
national  health  care  systems  mandating  the  search  for
pharmaceutical agents that can prevent or delay the onset of
cataract [8,9]. Oxidative damage resulting from free radicals
and/or H2O2 is considered to be a major risk factor in the
pathogenesis  of  both  age-related  and  diabetic  cataract
[10-13]. Elevated levels of H2O2 have been reported in the
aqueous humor of cataract patients, and free radicals and
H2O2  have  been  implicated  in  cataract  formation  [14,15].
Mitochondria  are  especially  sensitive  to  oxidative  stress.
H2O2  can  cause  the  collapse  of  mitochondrial  membrane
potential (Δψm) in many cell types including lens epithelial
cells, exacerbating free radical production [16,17]. It has been
reported that 17 β-estradiol (17β-E2) can protect human lens
epithelial  cells  against  oxidative  stress  by  preserving
mitochondrial function [17]. 17β-E2 stabilizes Δψm in cultured
human and bovine lens epithelial cells, acting as a positive
regulator of the mitogen-activated protein kinase (MAPK)
signal transduction pathway [18]. These effects did not require
prolonged exposure to estrogens, suggesting that estrogens are
acting at least in part via rapid non-genomic pathways. Studies
from  our  laboratory  recently  demonstrated  that  silencing
extracellular signal-regulated kinase 2 (ERK2) dramatically
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898increased membrane depolarization compared to non-specific
siRNA. That is, ERK2 regulates mitochondrial membrane
depolarization, termed, mitochondrial permeability transition
(MPT) in human lens epithelial cells, supporting the notion
that estrogen-induced activation of ERK2 acts to protect cells
from acute oxidative stress. Furthermore, despite the fact that
ERK2 plays a regulatory role on mitochondrial membrane
potential, it was reported that estrogen-blocked mitochondrial
membrane  depolarization  via  an  ERK-independent
mechanism [19]. Future studies will be aimed at discovering
the  means  by  which  phosphorylated  ERK  prevents  MPT.
Estrogen might directly associate with elements of the MPT
pore  or  indirectly  activate/promote  phosphorylation  of
mitochondrial protein components involved in the regulation
of the MPT pore, thus opposing the cell death machinery. Such
data will undeniably be of great importance to understanding
the  non-genomic,  estrogen-mediated  prevention  of
mitochondrial membrane depolarization.
The study reported herein illustrates the effects of 17β-
E2 on the expression and activity of mitochondrial-associated
manganese superoxide dismutase (MnSOD). A decrease in
SOD has been reported in diabetic patients [20]. It has also
been reported that MnSOD exerts a protective effect against
H2O2-induced oxidative stress in cultured lens epithelial cell
line, SRA 01/04 [21]. Cell cultures made deficient in MnSOD
by downregulating the enzyme have been shown to display a
pattern  of  mitochondrial  damage,  cytochrome  C  leakage,
caspase 3 activation, and increased apoptotic cell death when
challenged with a superoxide anion [22].
METHODS
HLE-B3 cells, a human lens epithelial cell line immortalized
by SV-40 viral transformation [23], were obtained from Usha
Andley  (Department  of  Ophthalmology,  Washington
University School of Medicine, St Louis, MO). Cells were
maintained at 37 °C in Eagle’s minimal essential medium
(MEM) supplemented with 20% fetal bovine serum (FBS;
Hyclone  Laboratories,  Logan,  UT),  2  mM  L-glutamine,
nonessential amino acids, and 0.02 g/l gentamicin solution
(Sigma  Chemical  Co,  St.  Louis,  MO)  in  an  environment
composed  of  5%  CO2/95%  O2.  All  experiments  were
performed  with  monolayers  of  HLE-B3  cells  between
passages 15–22. To deplete the cell cultures of estrogens, cells
were maintained in 20% FBS MEM for 24–48 h then switched
to 2% charcoal dextran-stripped FBS (CSFBS-MEM; Gemini
Bio-Products, Woodland, CA) for up to 18 h with a final
medium change to 0.5% CSFBS-MEM for 24 h.
1,3,5(10) estratrien-3, 17β-DIOL (17β-E2) was purchased
from  Steraloids  Inc.  (Newport,  RI).  The  hormone  was
dissolved in 100% ethanol, and stock solutions of hormone
were prepared fresh for each experiment and diluted in the
culture medium to a working concentration of 1 μM. Control
cells  received  an  equivalent  aliquot  of  ethanol.  Rabbit
polyclonal  antibody  against  human  SOD2  (MnSOD)  was
purchased from Abcam (Cambridge, MA). Rabbit polyclonal
antibody  against  actin  and  secondary  antibodies  were
purchased from Santa Cruz Biotechnology Inc. (Santa Cruz,
CA).
Reverse transcriptase/polymerase chain reaction: HLE-
B3 cells maintained in 75 cm2 culture flasks were harvested
by scraping and rinsed once with 1X PBS (pH 7.4) and then
pelleted by centrifugation at 3000x g for 5 min. Total RNA
was extracted using either a TRIzol® Reagent (Invitrogen
Corp, Carlsbad, CA) or a Trizol kit (Tel-Test, Friendswood,
TX) according to the supplier's protocol. RNA pellets were air
dried for 10 min and subsequently treated with Turbo DNA-
free (Ambion, Austin, TX) and dissolved in deionized water
as per manufacturer’s protocol. The concentration and purity
of the RNA preparation were determined by measuring the
absorbance of RNA at wavelengths 260 and 280 nm (Hitachi
Instruments Inc., Tokyo, Japan). RNA was stored at −80 °C
for subsequent experiments.
cDNA  was  prepared  with  AMV  reverse  transcriptase
(Promega,  Madison,  WI)  using  random  hexamer  primers
(Promega, Madison, WI). RNA was initially denatured at
85 °C for 3 min then placed on ice for 3–5 min. The reaction
was performed in a total volume of 20 μl containing 1.0 μg of
total RNA, 10 U of AMV reverse transcriptase, 25 ng μl−1
random  hexamer,  4  μl  of  5X  AMV  reverse  transcriptase
buffer,  4  μl  of  5  mM  MgCl2,  1  mM  dNTPs  (Promega,
Madison, WI), and 2 U/μl RNasin (Promega, Madison, WI).
The reaction was incubated at 42 °C for 45 min. Polymerase
chain reaction (PCR) primers were specifically designed for
MnSOD  using  Primer3  (MIT,  Cambridge,  MA)  and
synthesized by Sigma Genosys (Spring, TX).
For PCR reactions, 2.5 μl of cDNA from the reverse
transcriptase reactions was amplified in a total volume of
50 μl containing 0.2 μM of target gene primers (sense and
antisense), 0.75 mM MgCl2, 0.2 mM each of dATP, dGTP,
dCTP, and dTTP, 1 U of Taq polymerase (Promega, Madison,
WI), and 5 μl of 10X PCR buffer (Promega, Madison, WI).
Samples were overlaid with 200 μl mineral oil. Amplification
was performed on a Perkin Elmer DNA Thermal Cycler 480
(Perkin Elmer, Boston, MA) for 35 cycles. The authenticity
of  PCR  products  were  confirmed  by  DNA  sequencing
(Seqwright, Houston, TX) and by a BLAST search of the
sequence  through  the  National  Center  for  Biotechnology
Information (NCBI) database (data not shown).
Real-time  polymerase  chain  reaction:  Real-time  PCR
was performed (Mx3000P Real-Time System; Stratagene La
Jolla, CA) with PCR Master Mix (SYBR Green; Stratagene).
Each reaction contained 12.5 μl of 2X Master Mix, 500 nM
MnSOD forward and reverse primers, and 2.5 ng cDNA from
HLE-B3  cells  that  were  treated  with  estrogen  or  ethanol
(controls) at various time points of 0, 1.5, 3, 6, 12, and 24 h.
Cycle  threshold  (Ct)  values  were  normalized  to  the
housekeeper TATA binding protein (TBP), and comparative
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method. The specific primers used for MnSOD were 5′-CTG
ATT TGG ACA AGC AGC AA and MnSOD 3′-CTG GAC
AAA CCT CAG CCC TA, product size 199 bp and for TBP
5′- GAA ACG CCG AAT ATA ATC CCA and TBP 3′-GCT
GGA AAA CCC AAC TTC TG, product size 181 bp.
Cell  lysis,  electrophoresis,  and  western  blot:  After
treatments, total cell lysates were collected from HLE-B3
cultures by rinsing adherent cells with ice-cold 1X phosphate
buffered saline (PBS), pH 7.4, immediately followed by an
addition of lysis buffer (25 mM HEPES, pH 7.4, 0.25 NaCl,
0.5% IGEPAL [NP-40], 0.2% Triton X-100, 1 mM EGTA,
1 mM EDTA, 0.5 mM DTT, 10 mM NaF, 0.1 mM Na3VO4,
and a cocktail of protease inhibitors [Sigma-Aldrich, St Louis,
MO]) to the monolayers for 30 min at 4 °C. Lysates were
collected,  sonicated  for  5  s,  and  sampled  for  protein
concentration using the Bio-Rad protein assay buffer (Bio-
Rad Laboratories, Hercules, CA). Laemmli (3X SDS) buffer
was added to the lysates, which were subsequently boiled for
3 min, and the proteins were resolved by electrophoresis on
10%  SDS-polyacrylamide  gels  (20  μg  protein  per  lane).
Proteins  were  transferred  to  nitrocellulose  (Scheicher  and
Schuell, Keene, NH), and the membranes were blocked with
1% bovine serum albumin (BSA) and 0.02% NaN3 in Tween-
Tris-buffered saline (TTBS) for 15 min. Membranes were
probed for 3 h at room temperature and overnight at 4 °C with
primary antibodies (see Methods), rinsed in TTBS (4 times
for  5  min  each  time),  and  incubated  in  goat  anti-rabbit
horseradish peroxidase conjugate for 1 h at room temperature.
Required  concentrations  of  antibodies  were  determined
according to the manufacturer’s protocols. Membranes were
again rinsed in TTBS (4 times for 5 min each time), and
proteins  were  detected  using  a  SuperSignal  West  Pico
Chemiluminescent kit from Pierce (Rockford, IL). Probed
membranes  were  exposed  to  Kodak  BioMax  Light  Film
(Kodak Scientific Imaging, Rochester, NY).
Superoxide  dismutase  enzyme  activity  assay:  For
MnSOD activity evaluation, cells were lysed, collected with
a rubber policeman, and sonicated in cold 20 mM HEPES
buffer, pH 7.2 (EGTA 1 mM, 210 mM mannitol, and 70 mM
sucrose) followed by centrifugation at 1500x g for 5 min at
4  °C.  The  supernatant  was  subsequently  centrifuged  at
10,000x g for 15 min at 4 °C. The supernatant was evaluated
for MnSOD activity evaluation using a Superoxide Dismutase
Assay kit (#706002; Cayman Chemicals Inc., Ann Arbor, MI)
according to the manufacturer's protocol. The assay kit is
designed  to  measure  total  superoxide  dismutase  (SOD)
activity (cytosolic and mitochondrial). Separation of the two
enzyme  activities  was  achieved  as  directed  by  the
manufacturer's protocol. Briefly, the 1500x g supernatant of
the cell lysate was re-centrifuged at 10,000x g for 15 min at
4 °C. The resulting supernatant contains the cytosolic enzyme
(Cu/Zn-SOD), and the pellet contains the the mitochondrial
enzyme (MnSOD). The pellet was homogenized. The addition
of 1–3 mM potassium cyanide to the assay inhibits both Cu/
Zn-SOD  and  extracellular  SOD,  resulting  largely  in  the
detection of MnSOD alone.
Statistical  analysis:  For  the  MnSOD  enzyme  assay,
significant differences between groups were determined by an
independent sample Student’s t-test (2-tailed) using SPSS
version 12.0 for Windows. For quantitative polymerase chain
reaction (QPCR), normalized expression data were compared
by two-way ANOVA in all cases. For all experiments, data
are reported as mean±SEM or SD as indicated, and p values
<0.05 were considered significant.
RESULTS
Reverse transcriptase polymerase chain reaction detection of
manganese superoxide dismutase mRNA:  Total RNA was
extracted from cultured HLE-B3 cells and subjected to RT–
PCR for the detection of mitochondrial-associated MnSOD.
The resulting cDNA product yielded one band at the correct
predicted molecular weight (Figure 1).
Effect of 17β-E2 on manganese superoxide dismutase mRNA
expression: HLE-B3 cells were maintained in 75 cm2 culture
flasks in 20% FBS MEM for 24–48 h then switched to 2%
CSFBS-MEM for up to 18 h with a final medium change to
0.5% CSFBS-MEM for 24 h. Cells were incubated with either
Figure 1. Reverse transcriptase polymerase chain reaction expression
of manganese superoxide dismutase in HLE-B3 cells. Total RNA
was extracted from confluent HLE-B3 cells and subjected to RT–
PCR for MnSOD. The cDNA product yielded one band at the correct
predicted  molecular  weight  (199  bp).  The  authenticity  of  PCR
products was verified by DNA sequencing and a BLAST search of
the sequence (refer to Methods).
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9001 µM of 17β-E2 or ethanol-substituted control for 1.5, 3, 6, 12,
and 24 h. Each collected time point was compared to its
parallel control population of cells, which had not been treated
with 17β-E2. MnSOD mRNA was analyzed by real-time PCR
(Figure  2).  The  level  of  expressed  MnSOD  with  17β-E2
treatment was comparable to its non-treated counterpart. The
addition of 17β-E2 did not elicit any statistically significant
change in the levels of expressed MnSOD over the duration
of the time course.
Effect of 17β-E2 on MnSOD protein expression: HLE-B3 cells
were maintained in 0.5% CSFBS-MEM (see Methods). Cells
were incubated with 1 µM 17β-E2 for 1.5, 3, 6, 12, and 24 h.
The 0 h and one of the 24 h time points (indicated as 24* in
Figure 3) served as the controls and received an equivalent
ethanol  concentration  without  estrogen.  MnSOD  protein
expression  was  monitored  by  western  blot  analysis.  No
demonstrable change in the level of protein expression of
MnSOD was detected over the entire time course of collected
samples.
Effect of 17β-E2 on manganese superoxide dismutase activity:
Two  experiments  using  separate  cell  populations  were
performed  with  the  cells  maintained  in  0.5%  serum  as
described above. Cell cultures were incubated with 17β-E2 for
30 min and 90 min (Table 1) or 90 min and 6 h (Table 2) after
which  MnSOD  activity  was  immediately  determined.  No
statistically significant difference was observed in the samples
treated with 17β-E2 for 30 min in that there was no observed
increase in MnSOD activity with estrogen treatment relative
to the control cells not treated with estradiol (Table 1). The 90
min  incubation  with  1  µM  17β-E2  significantly  increased
MnSOD activity compared to the untreated controls, and this
was repeated with two independent experiments (see Table 1
and  Table  2).  A  second,  independent  experiment  was
performed over a longer duration of estradiol treatment (Table
2). Lens cells were likewise maintained in 0.5% serum, but
this time, they were incubated with 17β-E2 for 90 min and 6
h. As with the first set of treated cells (Table 1), 90 min of
incubation  with  1µM  17β-E2  increased  MnSOD  activity
compared to its untreated control counterpart (Table 2). No
statistically significant difference was observed between the
samples  treated  with  17β-E2  for  6  h  and  its  untreated
counterpart (Table 2), and more importantly, MnSOD activity
had returned to a level equivalent to that observed with 30 min
of treatment (Table 1).
DISCUSSION
Cellular  damage  caused  by  the  accumulation  of  reactive
oxygen species (ROS) has been implicated in many disease
processes, especially in age-related disorders. Lens cells are
particularly subject to oxidative stress due to photooxidative
processes and are consequently prone to cellular oxidative
damage  [24].  ROS  can  cause  oxidative  modifications  of
several  cellular  constituents  such  as  proteins,  cytoskeletal
TABLE 1. 17β-E2 UPREGULATES MANGANESE SUPEROXIDE DISMUTASE ACTIVITY.
Time
U/ml
Time
U/mg protein
Control (+) 17b E2 Control (+) 17b E2
30 min 54.9±6.1 67.7±6.5 30 min 24.5±5.3 29.4±5.1
90 min 66.4±9.1 104±12.1* 90 min 27.4±3.8 49.6±7.4*
HLE-B3 cells maintained in 0.5% serum were exposed to 1 μM 17β-E2 for 30 and 90 min (n=8, from two individual cell
populations±SEM). The control represents cells that were not treated with 17β-E2. Note the significant increase in activity
(asterisk) detected with the 90 min incubation treated with 17β-E2. The MnSOD activity (refer to Methods) was expressed as
units/ml (left panel) or units/mg protein (right panel). n=8 from two independent cell populations; the asterisk indicates statistical
significance as determined by Student’s t-test.
TABLE 2. 17β-E2 DOES NOT UPREGULATE MANGANESE SUPEROXIDE DISMUTASE ACTIVITY AFTER 6 H.
Time
U/ml
Time
U/mg protein
Control (+) 17b E2 Control (+) 17b E2
90 min 20.4±4.4 91±10.8* 90 min 11.6±3 62±8*
6 h 45±12 49±6 6 h 30±8 33±5
A second independent experiment with a fresh cell population was repeated over an extended time course with HLE-B3 cells
maintained in 0.5% serum and exposed to 1 μM 17β-E2 for 90 min and 6 h (n=8, from two individual cell populations±SEM).
The control represents cells that were not treated with 17β-E2. Note the significant increase in activity (asterisk) detected with
the 90 min incubation treated with 17β-E2 and the return to equivalent control activity levels by 6 h of treatment (compare 6 h
control versus 6 h +17β-E2). n=8; the asterisk indicates statistical significance as determined by Student’s t-test.
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901elements,  membrane  sulfhydryls,  glutathione  levels,  and
alterations  in  transport  systems  in  the  epithelium.  These
changes are in turn thought to result in lens opacification and
nuclear cataracts [21,25,26]. Mitochondria have been found
to be especially susceptible to oxidative damage. Oxidant
damage to the mitochondria can cause the release of calcium,
protein oxidation, depletion of ATP, lipid peroxidation, and
DNA damage [27]. The lens is equipped with antioxidant
enzymes, which can prevent the toxic effects of free radicals.
Superoxide anion is dismutated by the enzyme, superoxide
dismutase (SOD), to yield H2O2, which is then eliminated by
glutathione  peroxidase  and  catalase  [28].  There  are  three
isoforms of this enzyme, the cytosolic-CuZnSOD (SOD1),
mitochondrial superoxide dismutase MnSOD (SOD2), and
the extracellular SOD (ecSOD).
Various studies using tissue culture and animal models
have demonstrated the beneficial effects of estrogen in the lens
including the prevention or delay in the onset of cataract
formation [4-6]. The classic model that describes the action
of 17β-E2 illustrates 17β-E2 binding to a receptor and the
complex  then  being  transferred  to  specific  promoter-
regulatory  DNA  elements,  which  prompt  nuclear  gene
transcription activation or repression and subsequent protein
synthesis [7,29]. However, non-genomic actions of steroid
hormones  have  been  described.  Recent  work  from  this
laboratory has focused on investigating such alternative non-
genomic pathways to explain the rapid cytoprotective effects
of estrogens [17-19].
With respect to genomic response, there are several recent
studies with opposing results relating to the effect of estrogen
on the expression and activity of MnSOD. Using cultured
vascular smooth muscle endothelial cells, it has been reported
that the expression and the activity of MnSOD is enhanced by
estrogens.  Pre-incubation  with  1  µM  17β-E2  elevated  the
expression of MnSOD mRNA after 12 h. The protein level of
MnSOD was enhanced after 14 h followed by an increase in
MnSOD activity 24 h post-incubation. Furthermore, these
Figure  2.  Real-time  polymerase  chain  reaction  expression  of
manganese superoxide dismutase in HLE-B3 cells. HLE-B3 cells
were incubated with 1 μM 17β-E2 for 0, 1.5, 3, 6, 12, and 24 h. The
expression of MnSOD mRNA was analyzed by quantitative real-
time  PCR.  According  to  the  two-way  ANOVA,  there  were  no
statistically significant changes in MnSOD mRNA at any time point
after estrogen treatment compared to the control (untreated). Data
are expressed as mean±SD values. p<0.05 (n=3) was considered
significant.
effects on MnSOD expression and activity were reported to
be mediated by the activation of estrogen receptors as the
increased  expression  of  MnSOD  mRNA  was  blocked  by
incubation with estrogen receptor antagonist, ICI 182,780
[30]. In another study, it was reported that the human breast
carcinoma cells, MCF-7, when incubated with physiologic
concentrations of estrogen (0.02 nM) for a period of 48 h
demonstrated  an  increase  in  the  expression  of  MnSOD
mRNA, and the upregulation of MnSOD was linked to MAPK
and nuclear factor kappa (NFκB) signaling pathways [31]. It
was recently reported that 17β-estradiol significantly reduced
the rate of superoxide production in a receptor dependent
manner  using  rat  pheochromocytoma  cells  (PC-12  cells).
Gonadectomized  animals  were  treated  with  testosterone,
dihydrotestosterone, and estrogen to assess the in vivo effects
of gonadal hormones on brain mitochondrial oxidative stress
in  male  and  female  rats.  Only  estrogen  decreased  brain
mitochondrial ROS production in vivo. However, in apparent
opposition to the two studies reported above [30,31], estrogen
was  reported  to  increase  MnSOD  activity  levels  without
affecting the protein levels of MnSOD in mitochondria [32].
This observation has also been independently substantiated in
that estrogen upregulates the activity of MnSOD in a rapid
manner (10–20 min) but does not alter protein expression of
MnSOD in the mitochondria [33]. Thus, 17β-E2 seems to
enhance mRNA transcription, protein levels, and activity of
MnSOD in some cell systems while only increasing MnSOD
activity in others. Furthermore, it is noteworthy to point out
that  there  is  considerable  variability  as  to  the  timeframe
required (i.e., minutes versus hours) for the estrogen-mediated
response to increase MnSOD activity.
The study described herein also examined the effect of
estrogens on the expression and activity of MnSOD as part of
Figure 3. Western blot analysis of manganese superoxide dismutase
expression in HLE-B3 cells. Total cell lysates were collected from
HLE-B3 cells grown in 0.5% serum and stimulated by exposure to 1
μM 17β-E2 for 0, 1.5, 3, 6, 12, and 24 h. There was no change in the
expression of MnSOD at any of the time points. The time points at
0 and 24* hours did not receive estrogen.
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902our  preliminary  investigation  into  possible  cytoprotective
genomic  responses  by  estrogen  in  cultured  human  lens
epithelial cells. With the cultured lens epithelium system, no
change in the expression of MnSOD mRNA was observed
over 24 h post-incubation with estradiol according to results
obtained by real-time PCR (Figure 2). HLE-B3 cells treated
with  17β-E2  over  a  similar  time  course  also  showed  no
alteration  in  protein  expression  for  MnSOD  according  to
western  blot  analysis  (Figure  3).  However,  a  rapid  and
transient increase in the activity of MnSOD was observed
where the activity peaked in 90 min (Table 1 and Table 2) and
returned to control levels within 6 h (Table 2). This rapid and
transient increase in MnSOD activity unaccompanied by a
coupled change in its mRNA and protein expression argues
for non-genomic action of estradiol with cultured human lens
epithelial cells.
What  then  is  the  potential  mechanism  and  beneficial
effects of a mitochondrial MnSOD response mechanism that
senses a rapid (and as a result, transient) “spike” in reactive
oxygen species (ROS)? The accumulation of ROS, produced
by  a  wide  variety  of  exogenous  chemical  and  metabolic
processes, can play a dual role in biologic systems dependent
on the relative level of ROS intracellular concentration. ROS
can  either  be  beneficial  or  harmful  [34].  At  low
concentrations,  ROS  can  act  as  second  messengers  in
signaling  cascades  leading  to  the  induction  of  mitogenic
responses  whereas  at  higher  concentrations,  ROS  cause
damage  to  various  cellular  structures  including  lipids,
proteins, and nucleic acids [35]. Mitochondria are considered
to be a major source of ROS, which include superoxide anion
(O2
-), H2O2, and the hydroxyl free radical. These compounds
may  play  key  roles  as  signaling  molecules  regulating
mitochondrial dysfunction and subsequent apoptotic events.
It has been reported that exposure to estrogen stimulates the
rapid production of intracellular ROS in human umbilical vein
endothelial  cells  [36].  Estrogen-induced  mitochondrial
reactive oxygen species act as signal-transducing messengers
[37]. Studies have shown that estrogen causes an increase in
mitochondrial-associated  calcium  [38].  Ca2+  can  further
enhance  the  dislocation  of  cytochrome  c  from  the  inner
mitochondrial  membrane  by  competing  with  cardiolipin
binding  sites,  such  competition  results  in  the  blocking  of
complex III, which would enhance ROS generation [39]. An
increased  mitochondrial  formation  of  ROS  triggers  the
intrinsic pathway of apoptosis by increasing the permeability
of the outer mitochondrial membrane through the opening of
the mitochondrial permeability transition pore [40]. MnSOD
preserves mitochondrial function by regulating the sensitivity
of the permeability transition pore to ROS [41]. In our study,
the  endogenous  accumulation  of  reactive  oxygen  species
(ROS) was assessed in HLE-B3 cells treated with estrogen by
loading cells with H2DCF-DA, which upon oxidation in the
presence of ROS transitions to the fluorescent compound, 2,7
dichlorofluorescin (DCF). A statistically significant increase
in ROS was observed only after three days in estrogen-treated
cells relative to parallel control cell cultures.
Data presented herein supports the notion that the bolus
addition  of  17β-E2  causes  a  transient  increase  in  the
production of ROS in HLE-B3 cells but at the same time
constitutively induces MnSOD activity, which quenches the
ROS formed in the mitochondria and preserves mitochondrial
function. Chen et al. [42] have demonstrated that “a low level
of reactive oxygen species plays an important role in host
defense and mediating mitogen-stimulated cell signaling.”
This group has shown that the endogenous generation of ROS
initiates redox signaling, resulting in, among other things, the
activation of mitogen-activated protein kinases (MAPKs). To
that end, it is noteworthy to mention that we have previously
reported that cell death induced by H2O2 in cultured human
lens epithelial cells is associated with the accumulation of
intracellular  ROS,  the  collapse  of  the  mitochondrial
membrane potential (Δψm), and the depletion of ATP. When
estradiol is present, it requires more Ca2+ to induce comparable
Δψm collapse or conversely, under comparable Ca2+ loading,
a larger portion of the mitochondrial population retains its
membrane potential in the presence of estradiols [17]. It has
also been shown that 17β-E2 acts as a positive regulator of the
survival signal transduction pathway, MAPK, which, in turn,
acts to stabilize Δψm [18,19].
Our  conceptual  framework  regarding  the  protective
mechanism(s) activated by 17β-E2 is based on the premise that
cytoprotection will prove to be complex and multi-faceted
with both non-genomic and genomic aspects. We support the
notion  that  the  estrogen-driven  responses  driving
mitochondrial protection against membrane potential loss are
likely to prove to be dynamic. The protective stabilization of
mitochondrial  membrane  potential  by  estrogens  may  be
attributed  to  the  consolidation  of  several  mechanisms  of
action working in concert. To that end, we can now report that
there is a coupled duality to the mechanism of estradiol’s
cytoprotective action against acute oxidative stress. Estradiol
administration to HLE-B3 cells initiates a rapid increase in
intracellular (mitochondrial) ROS and transiently increases
MnSOD activity, which immediately acts to lower the ROS
concentration before mitochondrial damage might ensue. At
the  same  time,  estradiol  prompts  a  signaling  cascade
culminating in the activation of the ERK/MAPK pathway,
which exerts a positive effect by attenuating the extent of
depolarization of mitochondrial membrane potential in the
face of acute oxidative stress and thereby preventing entry into
the cell death pathway.
Other  mitochondrial  protective  mechanisms  against
oxidative stress are likely. The restraint of Δψm collapse might
be  explained  by  a  repression  of  Ca2+  uptake  into  the
mitochondria, increased tolerance to mitochondrial calcium
sequestration, increased Ca2+ efflux from the mitochondria,
increased resorption of Ca2+ into endoplasmic reticulum, and/
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903or increased efflux of Ca2+ via the plasma membrane. An
estrogen redox cycle has been proposed [43], which may
control glutathione and NAD(P)H flux, and in conjunction
with “classic” antioxidant responses [44], the the redox cycle
may be acting as a defense mechanism against reactive oxygen
species. Recently, it has been reported that protein kinase C
epsilon (PKCε) is activated by hypoxia, and this results in the
activation of the mitochondrial protein, cytochrome c oxidase
IV  subunit  (CytCOx).  This  potentially  provides  another
mechanism to protect the lens from mitochondrial damage
under the naturally hypoxic conditions observed in this tissue
[45].
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